BioSpace News Archive

Benuvia Manufacturing, LLC, a customer focused contract development and manufacturing organization (CDMO) and leading developer of active pharmaceutical ingredients and drug products, announced the appoin

The companies and Bolt Threads unite to form a first-of-its-kind Mylo consortium, a highly unique and creative collaborative partnership, to usher in a more sustainable future for fashion

BioCurity, a private preclinical biotech company with a mission to prevent radiation therapy’s side effects for cancer patients and survivors, received an issuance from the European Patent Office for BioCurity’s EP patent #3169312 entitled “Treatment of Cancer with a Combination of Radiation, Cerium Oxide Nanoparticles, and a Chemotherapeutic Agent.”

The Biotechnology Innovation Organization awarded Roy Cooper, Governor of North Carolina, with its 2020 Governor of the Year Award. Governor Cooper was presented the award virtually at NCBIO’s 2020 Annual Meeting.

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced the launch of AditxtEngage™, a continuing series of investor opportuniti

Xeris Pharmaceuticals, Inc. announced that on September 30, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 250 share of its common stock to 1 new employee under Xeris’ Inducement Equity Plan.

Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced the closing of a public offering of 2,769,231 Aptorum’s Class A ordinary shares (or ordinary share equivalents) and warrants to purchase up to 2,769,231 Class A Ordinary Shares, at a combined public

Sensient Technologies Corporation will hold its conference call to discuss 2020 third quarter results at 8:30 a.m. CDT on Friday, October 16, 2020.

Flexion Therapeutics, Inc. announced equity inducement grants to two new employees consisting of 3,315 restricted stock units.

Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2020 on Thursday, October 29, 2020 after the market closes.